Free Trial

Bio-Techne (TECH) SEC Filings & 10K Form

Bio-Techne logo
$64.92 -0.57 (-0.87%)
Closing price 04:00 PM Eastern
Extended Trading
$64.68 -0.25 (-0.38%)
As of 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Bio-Techne SEC Filings

DateFilerForm TypeView
02/07/2025
3:55 PM
Bio-Techne (Issuer)
Herr Amy E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
3:56 PM
Bio-Techne (Issuer)
Herr Amy E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Bio-Techne (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/05/2025
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
4:27 PM
Bio-Techne (Issuer)
Geist William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:31 PM
Bio-Techne (Issuer)
McManus Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:38 PM
Bio-Techne (Issuer)
McManus Matthew (Reporting)
Form 4/A
01/29/2025
3:35 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:24 PM
Bio-Techne (Subject)
Kelderman Kim (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
4:31 PM
Bio-Techne (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
11/05/2024
3:31 PM
Bio-Techne (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:33 PM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:40 PM
BAUMGARTNER ROBERT V (Reporting)
Bio-Techne (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:40 PM
Bio-Techne (Issuer)
Klimovsky Judith V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:41 PM
Bio-Techne (Issuer)
Seth Alpna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:41 PM
Bio-Techne (Issuer)
Nusse Roeland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:42 PM
Bio-Techne (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:42 PM
Bio-Techne (Issuer)
Bushman Julie L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:43 PM
Bio-Techne (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:44 PM
Bio-Techne (Issuer)
KEEGAN JOSEPH D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:02 AM
Bio-Techne (Filer)
Form DEF 14A
09/12/2024
6:02 AM
Bio-Techne (Filer)
Form DEFA14A
09/12/2024
6:04 AM
Bio-Techne (Filer)
Form ARS
08/22/2024
3:30 PM
Bio-Techne (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/19/2024
4:27 PM
Bio-Techne (Issuer)
McManus Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:28 PM
Bio-Techne (Issuer)
Bohnen Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:29 PM
Bio-Techne (Issuer)
Geist William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:29 PM
Bio-Techne (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:30 PM
Bio-Techne (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:08 PM
BAUMGARTNER ROBERT V (Reporting)
Bio-Techne (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:32 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:31 PM
Bio-Techne (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:35 PM
Bio-Techne (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
6:00 AM
Bio-Techne (Filer)
Form SD
Specialized Disclosure Report  
05/14/2024
3:10 PM
Bio-Techne (Subject)
HIGGINS JOHN L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
3:30 PM
Bio-Techne (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
5:30 AM
Bio-Techne (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:53 PM
Bio-Techne (Issuer)
Bohnen Shane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
2:03 PM
Bio-Techne (Subject)
Nusse Roeland (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TECH) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners